These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 3005882)
1. Opioid activities of human beta-casomorphins. Koch G; Wiedemann K; Teschemacher H Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):351-4. PubMed ID: 3005882 [TBL] [Abstract][Full Text] [Related]
2. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery. Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F Peptides; 1982; 3(5):793-7. PubMed ID: 6294635 [TBL] [Abstract][Full Text] [Related]
3. Rotational behaviour produced by intranigral injections of bovine and human beta-casomorphins in rats. Herrera-Marschitz M; Terenius L; Grehn L; Ungerstedt U Psychopharmacology (Berl); 1989; 99(3):357-61. PubMed ID: 2556724 [TBL] [Abstract][Full Text] [Related]
4. Acute and persistent effects of beta-funaltrexamine on the binding and agonist potencies of opioids in the myenteric plexus of the guinea-pig ileum. McKnight AT; Paterson SJ; Corbett AD; Kosterlitz HW Neuropeptides; 1984 Dec; 5(1-3):169-72. PubMed ID: 6099490 [TBL] [Abstract][Full Text] [Related]
5. CI-977, a novel and selective agonist for the kappa-opioid receptor. Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014 [TBL] [Abstract][Full Text] [Related]
6. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
7. Interaction of beta-casomorphins with multiple opioid receptors: in vitro and in vivo studies in the newborn rat brain. Volterra A; Restani P; Brunello N; Galli CL; Racagni G Brain Res; 1986 Nov; 395(1):25-30. PubMed ID: 3022888 [TBL] [Abstract][Full Text] [Related]
8. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Liebmann C; Schrader U; Brantl V Eur J Pharmacol; 1989 Aug; 166(3):523-6. PubMed ID: 2553436 [TBL] [Abstract][Full Text] [Related]
9. Receptors for opioid peptides in the guinea-pig ileum. Takemori AE; Portoghese PS J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432 [TBL] [Abstract][Full Text] [Related]
10. Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus. Fox AJ; Morton IK Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):8-15. PubMed ID: 1723152 [TBL] [Abstract][Full Text] [Related]
11. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain. Khawaja XZ; Green IC; Thorpe JR; Titheradge MA Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240 [TBL] [Abstract][Full Text] [Related]
12. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine. Hayes AG; Sheehan MJ; Tyers MB Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501 [TBL] [Abstract][Full Text] [Related]
13. PD117302: a selective agonist for the kappa-opioid receptor. Clark CR; Birchmore B; Sharif NA; Hunter JC; Hill RG; Hughes J Br J Pharmacol; 1988 Mar; 93(3):618-26. PubMed ID: 2836012 [TBL] [Abstract][Full Text] [Related]
14. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum. Elliott J; Traynor JR Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641 [TBL] [Abstract][Full Text] [Related]
15. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824 [TBL] [Abstract][Full Text] [Related]
16. Binding capacities and affinities at mu-, delta- and kappa-opioid sites in membrane suspensions from guinea-pig brain regions. La Regina A; Colombo M; Petrillo P; Tavani A J Recept Res; 1992; 12(2):171-80. PubMed ID: 1316438 [TBL] [Abstract][Full Text] [Related]
17. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
18. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain. Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Kayakiri H; Rothman RB Peptides; 1995; 16(6):1083-95. PubMed ID: 8532593 [TBL] [Abstract][Full Text] [Related]
19. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site. Cotton R; Kosterlitz HW; Paterson SJ; Rance MJ; Traynor JR Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685 [TBL] [Abstract][Full Text] [Related]
20. Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum. Nishiwaki H; Saitoh N; Nishio H; Takeuchi T; Hata F Jpn J Pharmacol; 1998 Aug; 77(4):279-86. PubMed ID: 9749928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]